Symptoms of Depression in Patients with Chemosensory Disorders.


Journal

ORL; journal for oto-rhino-laryngology and its related specialties
ISSN: 1423-0275
Titre abrégé: ORL J Otorhinolaryngol Relat Spec
Pays: Switzerland
ID NLM: 0334721

Informations de publication

Date de publication:
2021
Historique:
received: 09 05 2020
accepted: 13 12 2020
pubmed: 24 3 2021
medline: 22 5 2021
entrez: 23 3 2021
Statut: ppublish

Résumé

Patients with chemosensory dysfunction frequently report symptoms of depression. The current study aims to clarify whether the type (smell dysfunction, taste dysfunction, and mixed smell and taste dysfunction), severity, duration, or cause of dysfunction have differential impacts on the symptoms of depression. 899 patients with chemosensory disorders and 62 controls were included. Following a structured interview and an otorhinolaryngological examination, subjects underwent olfactory tests (Sniffin' Sticks), gustatory tests (taste sprays) and an assessment of depressive symptoms (Beck Depression Inventory). Information on the cause and duration of disorders was also collected. Patients with combined olfactory/gustatory dysfunction had higher depression scores than patients with smell dysfunction only and controls, and no significant difference was found between the smell dysfunction and controls. Anosmia patients, but not hyposmia patients, exhibited higher depression scores than controls. Among various causes of chemosensory disorders, patients from the posttraumatic group had higher depression scores than patients with other causes of chemosensory dysfunction (sinonasal, idiopathic, or postinfectious). Multiple linear regression analyses suggested that reduced olfactory function was associated with enhanced depression scores in the olfactory disorders group (B = -0.326, t = -2.294, and p = 0.02) and in all patients with chemosensory disorders (B = -0.374, t = -2.550, p = 0.017). Simultaneously decreased input of olfaction and gustation seems to have an additive effect on the exacerbation of emotional dysfunction. Early intervention should be considered for depression symptoms in patients with mixed olfactory/gustatory dysfunction in clinical practice.

Identifiants

pubmed: 33756467
pii: 000513751
doi: 10.1159/000513751
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

135-143

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Ben Chen (B)

Department of Otorhinolaryngology, Smell & Taste Clinic, TU Dresden, Dresden, Germany, chenbenpielo@sina.com.
Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China, chenbenpielo@sina.com.

Cara Benzien (C)

Department of Otorhinolaryngology, Smell & Taste Clinic, TU Dresden, Dresden, Germany.

Vanda Faria (V)

Department of Otorhinolaryngology, Smell & Taste Clinic, TU Dresden, Dresden, Germany.
Department of Psychology, Uppsala University, Uppsala, Sweden.
Department of Anesthesiology, Center for Pain and the Brain, Perioperative and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Yuping Ning (Y)

Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.

Mandy Cuevas (M)

Department of Otorhinolaryngology, Smell & Taste Clinic, TU Dresden, Dresden, Germany.

Jana Linke (J)

Department of Otorhinolaryngology, Smell & Taste Clinic, TU Dresden, Dresden, Germany.

Ilona Croy (I)

Department of Psychosomatic Medicine, TU Dresden, Dresden, Germany.

Antje Haehner (A)

Department of Otorhinolaryngology, Smell & Taste Clinic, TU Dresden, Dresden, Germany.

Thomas Hummel (T)

Department of Otorhinolaryngology, Smell & Taste Clinic, TU Dresden, Dresden, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH